At current levels, we recommend prospective investors to opt for GSK as compared to GILD on the back of a strong and wide ...

That shows how the company is now overvalued in our view. The largest risk to our thesis is if Gilead Sciences can achieve ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc.

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some ...

Congresswoman Marjorie Taylor Greene has made a name for herself in the stock market by having a knack for timing ...

When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but the ...

Increasing awareness, improved healthcare access, and next-gen diagnostic tools fuel steady 5.10% CAGR growth in the HIV diagnostics market through 2 ...

Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Co. (DIS), Gilead Sciences ...

Gilead to Pay $202 Million to Settle DOJ Claims Over Speaker Program Kickbacks - Gilead Sciences, Inc. has agreed to pay $202 ...

Gilead has a strong HIV franchise with flagship treatment Biktarvy driving the growth. The company’s efforts to develop innovative HIV treatments for prevention are impressive as well.

Gilead has a strong HIV franchise with flagship treatment Biktarvy driving the growth. The company’s efforts to develop innovative HIV treatments for prevention are impressive as well. Total sales ...

Gilead’s Q1 EPS exceeded forecasts, but revenue missed expectations. Stock dropped 3.4% in after-hours trading following the earnings release. HIV product sales, particularly Biktarvy, showed strong ...